THRESHOLD PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • June 27th, 2017 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • California
The Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of March 16, 2017 (the “Effective Date”), by and between ___ (the “Employee”) and Threshold Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • June 27th, 2017 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of June 23, 2017 (the “Effective Date”) by and among Molecular Templates, Inc., a Delaware corporation (“MTEM”), Threshold Pharmaceuticals, Inc., a Delaware corporation (“Threshold”), and Millennium Pharmaceuticals, Inc., a Delaware corporation and a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd. (the “Investor”). MTEM, Threshold and the Investor may each be referred to herein individually as a “Party” and collectively as the “Parties.”
